Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 1.00 |
| ▸ | HPGD | P15428 | 8/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | MAPT | P10636 | 11/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E324 SCHEMBL21601 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL7999894 | 1.00 | ALDH1A1 (1.00) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL27554157 | 0.98 | ALDH1A1 (0.97) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL27314758 | 0.98 | ALDH1A1 (0.97) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL27371041 | 0.98 | ALDH1A1 (0.97) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL27419374 | 0.98 | ALDH1A1 (0.97) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL11191719 | 0.98 | ALDH1A1 (0.97) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL8118295 | 0.98 | ALDH1A1 (0.97) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL27325190 | 0.98 | ALDH1A1 (0.97) | ALDH1A1KDM4EHPGDHSD17B10LMNA | |
| E324 SCHEMBL27951085 | 0.98 | ALDH1A1 (0.97) | ALDH1A1KDM4EHPGDHSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022229983-A1 | SUGAR ESTERS AND SUGAR ALCOHOL ESTERS OF SHORT CHAIN FATTY ACIDS AND COMPOSITIONS THEREOF | FERTIS INDIA PVT. LTD. (IN) | 2022-11-03 | — | — | WO | claimed |
| US-12589075-B2 | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof | AUSPEX PHARMACEUTICALS LLC (US) | 2026-03-31 | — | — | US | disclosed |
| US-12447182-B2 | Swine origin probiotics that promote health and growth performance in pigs | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250313777-A1 | TREATMENT COMPOSITIONS COMPRISING ETHOXYQUIN | PROCTER & GAMBLE COMPANY, THE | 2025-10-09 | — | — | US | disclosed |
| WO-2025199382-A1 | TREATMENT COMPOSITIONS COMPRISING ETHOXYQUIN | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-25 | — | — | WO | disclosed |
| US-12364720-B2 | Bacillus strains improving health and performance of production animals | NOVOZYMES A/S (DK) | 2025-07-22 | — | — | US | disclosed |
| US-12325646-B2 | Fertigation water treatment | UNIVERSITY OF GUELPH (CA) | 2025-06-10 | — | — | US | disclosed |
| US-20250121016-A1 | SWINE ORIGIN PROBIOTICS THAT PROMOTE HEALTH AND GROWTH PERFORMANCE IN PIGS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS | 2025-04-17 | — | — | US | disclosed |
| US-12220435-B2 | Swine origin probiotics that promote health and growth performance in pigs | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 2025-02-11 | — | — | US | disclosed |
| US-20240307313-A1 | OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF | AUSPEX PHARMACEUTICALS LLC | 2024-09-19 | — | — | US | disclosed |
| CN-114501995-A | Agricultural and horticultural insecticide or animal external or internal parasite control agent containing substituted cyclopropane oxadiazolyl-containing imidazopyridazine compound or salt thereof as active ingredient, and method for using same | 日本农药株式会社 | 2022-05-13 | — | — | CN | disclosed |
| US-20220143110-A1 | Bacillus Strains Improving Health and Performance of Production Animals | NOVOZYMES A/S (DK) | 2022-05-12 | — | — | US | disclosed |
| EP-3990605-A1 | CLEANING COMPOSITION | The Procter & Gamble Company (US) | 2022-05-04 | — | — | EP | disclosed |
| CN-110121500-B | 4H-pyrrolopyridine compound or salt thereof, agricultural or horticultural insecticide containing same, and method for using same | 日本农药株式会社 | 2022-05-03 | — | — | CN | disclosed |
| CN-110114354-B | Condensed heterocyclic compound having oxime group or salt thereof, agricultural and horticultural insecticide containing the same, and method of using the same | 日本农药株式会社 | 2022-04-29 | — | — | CN | disclosed |
| CN-114401967-A | Agricultural and horticultural insecticide or external or internal parasite control agent for animals containing imidazopyridazine compound or salt thereof as active ingredient, and method of use thereof | 日本农药株式会社 | 2022-04-26 | — | — | CN | disclosed |
| CN-114223661-A | Use of acyclic picolinamides as fungicides for controlling phytopathogenic fungi in row crops | 美国陶氏益农公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-114144419-A | Oxazepinotrienone derivative, agricultural or horticultural insecticide containing the derivative, and method of using the same | 日本农药株式会社 | 2022-03-04 | — | — | CN | disclosed |
| US-20220023283-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEMENTIA AND CEREBROVASCULAR DISORDERS | FUSO PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2022-01-27 | — | — | US | disclosed |
| EP-3942010-A1 | PROCESS OF LAUNDERING FABRICS | The Procter & Gamble Company (US) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220023283-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEMENTIA AND CEREBROVASCULAR DISORDERS | HTR3B, HTR3A, HTR2A | ALDH1A1 2184/4885KDM4E 1814/4885HPGD 1115/4885 |
| US-12589075-B2 | Osmotic dosage forms comprising deutetrabenazine and methods of use thereof | SLC6A3, HTT, PARK7 | ALDH1A1 3515/4885KDM4E 1600/4885HPGD 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.